Showing 1 - 7 results of 7 for search 'Philip L McCarthy', query time: 0.03s Refine Results
  1. 1
    Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease

    Fludarabine and cyclophosphamide provides a nonmyeloablative alternative conditioning regimen with low transplant-related mortality and control of high risk disease by Pamela Paplham, Theresa Hahn, Karen Dubel, Patricia Lipka, Philip L. McCarthy

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Future Directions in Maintenance Therapy in Multiple Myeloma

    Future Directions in Maintenance Therapy in Multiple Myeloma by Sarah A. Holstein, Vera J. Suman, Jens Hillengass, Philip L. McCarthy

    Published 2021-05-01
    Get full text
    Article
  3. 3
    Common genetic variants are associated with accelerated bone mineral density loss after hematopoietic cell transplantation.

    Common genetic variants are associated with accelerated bone mineral density loss after hematopoietic cell transplantation. by Song Yao, Lara E Sucheston, Shannon L Smiley, Warren Davis, Jeffrey M Conroy, Norma J Nowak, Christine B Ambrosone, Philip L McCarthy, Theresa Hahn

    Published 2011-01-01
    Get full text
    Article
  4. 4
    Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee

    Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee by Shaji Kumar, Lawrence Baizer, Natalie S. Callander, Sergio A. Giralt, Jens Hillengass, Boris Freidlin, Antje Hoering, Paul G. Richardson, Elena I. Schwartz, Anthony Reiman, Suzanne Lentzsch, Philip L. McCarthy, Sundar Jagannath, Andrew J. Yee, Richard F. Little, Noopur S. Raje

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation

    Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation by Hemn Mohammadpour, Takemasa Tsuji, Cameron R. MacDonald, Joseph L. Sarow, Hanna Rosenheck, Saeed Daneshmandi, Jee Eun Choi, Jingxin Qiu, Junko Matsuzaki, Agnieszka K. Witkiewicz, Kristopher Attwood, Bruce R. Blazar, Kunle Odunsi, Elizabeth A. Repasky, Philip L. McCarthy

    Published 2023-03-01
    Get full text
    Article
  6. 6
    Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies

    Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies by Saeed Daneshmandi, Jee Eun Choi, Qi Yan, Cameron R. MacDonald, Manu Pandey, Mounika Goruganthu, Nathan Roberts, Prashant K. Singh, Richard M. Higashi, Andrew N. Lane, Teresa W-M. Fan, Jianmin Wang, Philip L. McCarthy, Elizabeth A. Repasky, Hemn Mohammadpour

    Published 2024-03-01
    Get full text
    Article
  7. 7
    Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

    Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma by Maximilian Merz, Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson, Cherie Rondeau, Kimberly Celotto, Ahmed Belal, Ronald Alberico, AnneMarie W. Block, Hemn Mohammadpour, Paul K. Wallace, Joseph Tario, Jesse Luce, Sean T. Glenn, Prashant Singh, Megan M. Herr, Theresa Hahn, Mehmet Samur, Nikhil Munshi, Song Liu, Philip L. McCarthy, Jens Hillengass

    Published 2022-02-01
    Get full text
    Article

Search Tools: